Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer
cells, either by killing the cells or by stopping them from dividing. It is not yet known
which regimen of combination chemotherapy is more effective for Hodgkin lymphoma.
PURPOSE: This phase II trial is studying the side effects of three different regimens of
combination chemotherapy and to see how well they work in treating younger patients with
Hodgkin lymphoma.